Bangkok Dusit Medical Services PCL ADR (BDUUY) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Bangkok Dusit Medical Services PCL ADR stock forecast from 0 analysts, the average analyst target price for Bangkok Dusit Medical Services PCL ADR is not available over the next 12 months. Bangkok Dusit Medical Services PCL ADR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bangkok Dusit Medical Services PCL ADR is Slightly Bullish , which is based on 8 positive signals and 5 negative signals. At the last closing, Bangkok Dusit Medical Services PCL ADR’s stock price was USD 31.21. Bangkok Dusit Medical Services PCL ADR’s stock price has changed by +0.00% over the past week, -3.93% over the past month and +3.53% over the last year.
No recent analyst target price found for Bangkok Dusit Medical Services PCL ADR
No recent average analyst rating found for Bangkok Dusit Medical Services PCL ADR
Company Overview Bangkok Dusit Medical Services PCL ADR
Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally. The company operates hospitals under the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group names. It also offers laboratory, clinic, holistic clinical wellness, accounting, technology and information, training, investment and asset management, air transportation, skin and aesthetics telemedicine, and whole genome sequencing services; operates hotels; provides health insurance and insurance brokerage services; and distributes health products, cosmetic products, and facility management. In addition, the company is involved in production and distribution of medicines and pharmaceutical products; real estate; e-commerce; and investment and operation of BDMS silver wellness and residence products. Bangkok Dusit Medical Services Public Company Limited was founded in 1969 and is based in Bangkok, Thailand. Read Less
Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally. The company operates hospitals under the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospi...Read More
Frequently Asked Questions About Bangkok Dusit Medical Services PCL ADR (BDUUY) Stock
Stock Target Advisor's fundamental analysis for Bangkok Dusit Medical Services PCL ADR's stock is Slightly Bullish .
BDUUY stock's dividend yield is 2.47%.
Our analysis grades BDUUY stock's dividend yield at F. This means that BDUUY stock's dividend yield is above 50% of the stocks in the Medical Care Facilities sector in the OTC exchange.
Based on this BDUUY may be a average dividend stock for its sector.
Unfortunately we do not have enough data on BDUUY's stock to indicate what its average analyst target is.
BDUUY stock's Price/Earning ratio is 31.85.
Our analysis grades BDUUY stock's Price / Earning ratio at F. This means that BDUUY stock's Price/Earning ratio is above 65.99999999999999% of the stocks in the Medical Care Facilities sector in the OTC exchange.
Based on this BDUUY may be a overvalued for its sector.
The last closing price of BDUUY's stock was USD 31.21.
The most recent market capitalization for BDUUY is USD 12.40B.
Unfortunately we do not have enough analyst data on BDUUY's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bangkok Dusit Medical Services PCL ADR's stock.
As per our most recent records Bangkok Dusit Medical Services PCL ADR has 0 Employees.
Bangkok Dusit Medical Services PCL ADR's registered address is 2, Soi Soonvijai 7, Bangkok, Thailand, 10310.
You can get more information about it from Bangkok Dusit Medical Services PCL ADR's website at https://www.bdms.co.th.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BDUUY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
